Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy

Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs), the estimated annual incidence being 1–2 cases per 100,000 inhabitants. The aim of this review was to summarize the main morphologic features of UTUC as well as the current status and future role of its molecular characterization in diagnosis, prognosis, and therapy. Areas covered: Several studies on the UTUCs have shown the diagnostic, prognostic, and therapeutic significance of standard pathological features, such as tumor stage, grade, and lymph node metastasis. Investigations have also identified novel factors, in particular, variant histologies, and molecular biomarkers. Based on these, predictive tools have been developed. Expert commentary: The morphology of the UTUC has been considered to be the same as that of Bladder Urothelial carcinoma (BUC). Molecular characterization studies, including genomics, have shown changes in UTUC occurring at differing frequencies in comparison with BUC, the former with unique molecular subtypes and different responses to treatment.

Original languageEnglish (US)
Pages (from-to)1021-1028
Number of pages8
JournalExpert Review of Molecular Diagnostics
Volume18
Issue number12
DOIs
StatePublished - Dec 2 2018

Fingerprint

Urinary Tract
Carcinoma
Therapeutics
Urinary Bladder
Genomics
Histology
Biomarkers
Lymph Nodes
Neoplasm Metastasis
Incidence
Neoplasms

Keywords

  • cancer variants
  • molecular characterization
  • personalized approach
  • predictive models
  • Upper tract urothelial carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Upper urinary tract urothelial carcinoma and its variants : transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy. / Cimadamore, Alessia; Scarpelli, Marina; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo.

In: Expert Review of Molecular Diagnostics, Vol. 18, No. 12, 02.12.2018, p. 1021-1028.

Research output: Contribution to journalReview article

Cimadamore, Alessia ; Scarpelli, Marina ; Santoni, Matteo ; Cheng, Liang ; Lopez-Beltran, Antonio ; Montironi, Rodolfo. / Upper urinary tract urothelial carcinoma and its variants : transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy. In: Expert Review of Molecular Diagnostics. 2018 ; Vol. 18, No. 12. pp. 1021-1028.
@article{8e93b82c80ee49159c63156f880e365b,
title = "Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy",
abstract = "Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5{\%} of urothelial carcinomas (UCs), the estimated annual incidence being 1–2 cases per 100,000 inhabitants. The aim of this review was to summarize the main morphologic features of UTUC as well as the current status and future role of its molecular characterization in diagnosis, prognosis, and therapy. Areas covered: Several studies on the UTUCs have shown the diagnostic, prognostic, and therapeutic significance of standard pathological features, such as tumor stage, grade, and lymph node metastasis. Investigations have also identified novel factors, in particular, variant histologies, and molecular biomarkers. Based on these, predictive tools have been developed. Expert commentary: The morphology of the UTUC has been considered to be the same as that of Bladder Urothelial carcinoma (BUC). Molecular characterization studies, including genomics, have shown changes in UTUC occurring at differing frequencies in comparison with BUC, the former with unique molecular subtypes and different responses to treatment.",
keywords = "cancer variants, molecular characterization, personalized approach, predictive models, Upper tract urothelial carcinoma",
author = "Alessia Cimadamore and Marina Scarpelli and Matteo Santoni and Liang Cheng and Antonio Lopez-Beltran and Rodolfo Montironi",
year = "2018",
month = "12",
day = "2",
doi = "10.1080/14737159.2018.1549490",
language = "English (US)",
volume = "18",
pages = "1021--1028",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Upper urinary tract urothelial carcinoma and its variants

T2 - transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy

AU - Cimadamore, Alessia

AU - Scarpelli, Marina

AU - Santoni, Matteo

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

PY - 2018/12/2

Y1 - 2018/12/2

N2 - Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs), the estimated annual incidence being 1–2 cases per 100,000 inhabitants. The aim of this review was to summarize the main morphologic features of UTUC as well as the current status and future role of its molecular characterization in diagnosis, prognosis, and therapy. Areas covered: Several studies on the UTUCs have shown the diagnostic, prognostic, and therapeutic significance of standard pathological features, such as tumor stage, grade, and lymph node metastasis. Investigations have also identified novel factors, in particular, variant histologies, and molecular biomarkers. Based on these, predictive tools have been developed. Expert commentary: The morphology of the UTUC has been considered to be the same as that of Bladder Urothelial carcinoma (BUC). Molecular characterization studies, including genomics, have shown changes in UTUC occurring at differing frequencies in comparison with BUC, the former with unique molecular subtypes and different responses to treatment.

AB - Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs), the estimated annual incidence being 1–2 cases per 100,000 inhabitants. The aim of this review was to summarize the main morphologic features of UTUC as well as the current status and future role of its molecular characterization in diagnosis, prognosis, and therapy. Areas covered: Several studies on the UTUCs have shown the diagnostic, prognostic, and therapeutic significance of standard pathological features, such as tumor stage, grade, and lymph node metastasis. Investigations have also identified novel factors, in particular, variant histologies, and molecular biomarkers. Based on these, predictive tools have been developed. Expert commentary: The morphology of the UTUC has been considered to be the same as that of Bladder Urothelial carcinoma (BUC). Molecular characterization studies, including genomics, have shown changes in UTUC occurring at differing frequencies in comparison with BUC, the former with unique molecular subtypes and different responses to treatment.

KW - cancer variants

KW - molecular characterization

KW - personalized approach

KW - predictive models

KW - Upper tract urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85057746514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057746514&partnerID=8YFLogxK

U2 - 10.1080/14737159.2018.1549490

DO - 10.1080/14737159.2018.1549490

M3 - Review article

C2 - 30452305

AN - SCOPUS:85057746514

VL - 18

SP - 1021

EP - 1028

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 12

ER -